144
Views
4
CrossRef citations to date
0
Altmetric
Case Series

Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine–Gass Syndrome

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon &
Pages 127-132 | Published online: 26 Feb 2021

References

  • Kodjikian L, Bellocq D, Bodaghi B. Management of Irvine-Gass syndrome. J Fr Ophtalmol. 2017;40(9):788–792. doi:10.1016/j.jfo.2017.09.001
  • Grzybowski A, Sikorski B, Ascaso F, Huerva V. Pseudophakic cystoid macular edema: update 2016. Clin Interv Aging. 2016;11:1221–1229. doi:10.2147/CIA.S111761
  • Guo S, Patel S, Baumrind B, et al. Management of pseudophakic cystoid macular edema. Surv Ophthalmol. 2015;60(2):123–137. doi:10.1016/j.survophthal.2014.08.005
  • Shelsta H, Jampol L. Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina. 2011;31(1):4–12. doi:10.1097/IAE.0b013e3181fd9740
  • Oliveira Dias J, Nunes R, Goldhardt R. New drugs and new posterior delivery methods in CME. Curr Ophthalmol Rep. 2017;5(2):160–168. doi:10.1007/s40135-017-0134-3
  • Pearce W, Hsu J, Yeh S. Advances in drug delivery to the posterior segment. Curr Opin Ophthalmol. 2015;26(3):233–239. doi:10.1097/ICU.0000000000000143
  • Campochiaro P, Brown D, Pearson A, et al., FAME Study Group. Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmol. 2012;119(10):2125–2132. doi:10.1016/j.ophtha.2012.04.030
  • Ong S, Walter S, Chen X, Thomas A, Finn A, Fekrat S. Bilateral intravitreal 0.19-mg fluocinolone acetonide implant for persistent nondiabetic cystoid macular edema after vitrectomy. Retin Cases Brief Rep. 2018;12(1):1–5. doi:10.1097/ICB.0000000000000432
  • Bellocq D, Korobelnik J, Burillon C, et al. Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol. 2015;99(7):979–983. doi:10.1136/bjophthalmol-2014-306159
  • Bellocq D, Pierre-Kahn V, Matonti F, et al. Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol. 2017;101(3):333–341. doi:10.1136/bjophthalmol-2016-308544
  • Ohn MT, Thompson E, Waghmare A, Chandra A, Karia N. Usefulness of Intravitreal dexamethasone implant in treatment of persistent cystoid macular edema due to Irvine–Gass syndrome. J Clin Res Ophthalmol. 2019;6(1):1–6.